Janet Ruffin

Retired Nurse Executive and Conservative Republican.

[Nicolas Hulscher, MPH @NicHulscher]

BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal

84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.

Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.

The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.

Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.

At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)

Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.

Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.

This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.

With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.

In the meantime, many cancer patients are exercising their right to try.

@twc_health @McCulloughFund @IIAR_Journals @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson

[Janet Ruffin @janruffin1]

@CraigBrockie Probiotics

[Janet Ruffin @janruffin1]

@mymomcare I agree with you. It pains me to watch her.

[Janet Ruffin @janruffin1]

@DrOz is there a hotline number to call and report DME Medicare fraud? Experienced it here at home and want to be sure it is being audited. Thanks!

[DogeDesigner @cb_doge]

BREAKING: Nick Shirley’s Minnesota Somali fraud video just crossed 100 million views on X.

You are the media now!

[Janet Ruffin @janruffin1]

@RedLineReportt a

[Nick shirley @nickshirleyy]

🚨 Here is the full 42 minutes of my crew and I exposing Minnesota fraud, this might be my most important work yet. We uncovered over $110,000,000 in ONE day. Like it and share it around like wildfire! Its time to hold these corrupt politicians and fraudsters accountable

We ALL work way too hard and pay too much in taxes for this to be happening, the fraud must be stopped.

[Janet Ruffin @janruffin1]

@Longevity_EDU Cookbook please

[Liz Churchill @liz_churchill10]

Big Pharma has been pathologically lying to you…

“The most impressive of all is that Ivermectin Cream completely clears Skin Cancers…and it will also heal Inflammatory Autoimmune Skin Conditions like Cystic Acne, Eczema and Rosacea…”

[Not A Number @myhiddenvalue]

They're lying about cancer like they lied about Covid

[Janet Ruffin @janruffin1]

#NewProfilePic

[Sara Haboubi @SaraHaboubi1]

Soon-Shiong’s “Bioshield” Sparks Early Promise in Recurrent GBM, With 2 Near-CRs and 100% Disease Control - OncoDaily https://t.co/f7u9ZcDabW

[Camus @newstart_2024]

A Cancer Breakthrough That Changes Everything

In a stunning medical advance, Dr. Patrick Soon-Shiong reveals a platform technology achieving near-complete responses in patients with terminal cancers—including brain, pancreatic, and head & neck tumors—after all other treatments failed.

This isn't a traditional chemo or radiation. It's a dual approach that empowers the body's own immune system.

Here’s the revolutionary breakdown:

1. The "BioShield" Injection: The key is a stabilized form of IL-15 (Interleukin-15), a protein that acts as "food" for your Natural Killer (NK) cells. The NIH tried for a decade to develop IL-15 but failed because it naturally lasts only 2 minutes in the body. Dr. Soon-Shiong's team engineered it to last for 7 days with a simple 5-minute subcutaneous injection, continuously proliferating the patient's NK cells.

2. The Combined Infusion: Patients receive this "BioShield" injection along with an infusion of powerful NK cells, creating a targeted army to attack the cancer.

The Proven Results:

- Metastatic Pancreatic Cancer: Patients alive 6 years later.

- Merkel Cell Carcinoma: Patients surviving 9 years.

- Bladder Cancer: Approved by the FDA in April 2024, with patients disease-free for 10 years.

- Lung Cancer: In new trials, the therapy has tripled survival for patients who failed everything, including chemo and checkpoint inhibitors.

The therapy is also being used preemptively. The NCI has designated it for a trial on patients with Lynch syndrome (1 in 280 Americans), who have an 80% higher risk of cancers, to provide a "Cancer BioShield."

The data is based on experience with over 8,000 patients. The challenge now is regulatory. Despite its pan-tumor potential, the current system requires a separate 10-year, 700,000-page approval process for each cancer type.

This is a paradigm shift. We don't ask what kind of anemia you have before a blood transfusion. The body needs NK cells and T-cells to fight cancer, regardless of the tumor type.

[Brit Hume @brithume]

Worth remembering.

[Benny Johnson @bennyjohnson]

Secretary of War Pete Hegseth delivers a powerful postgame locker room speech following Navy’s 34-31 win over Air Force.

"You got it done."

[Eric Daugherty @EricLDaugh]

🔥 JUST IN: Secretary of War Pete Hegseth helped set a new Guinness WORLD RECORD as 3,068 people did pushups at the same time for one minute straight.

He did it on the field with the Naval Academy.

America respects the secretary of war 🇺🇸

[Pete Hegseth @PeteHegseth]

Today, we end the War on Warriors.

[Janet Ruffin @janruffin1]

@NFL. You lost me this year. I refuse to watch any NFL game knowing that you have signed Bad Bunny for the Super Bowl. What were you thinking. I hope you reconsider and cancel this show.

[Janet Ruffin @janruffin1]

@its_The_Dr 66 years young and no tattoos. I will never.